 | • レポートコード：MRC2312MG11870 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、61ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の馬獣医治療市場規模と予測を収録しています。・世界の馬獣医治療市場：売上、2018年-2023年、2024年-2029年 ・世界の馬獣医治療市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の馬獣医治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「医薬品」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 馬獣医治療のグローバル主要企業は、Boehringer Ingelheim、 Merck Animal Health、 Zoetis、 Elanco Animal Health、 Dechra Veterinary Products、 CEVA、 Virbac、 Norbrook Equine、 Kyoritsu Seiyaku、 Vetoquinol、 Protexin Healthcare、 Audevardなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、馬獣医治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の馬獣医治療市場：タイプ別、2018年-2023年、2024年-2029年 世界の馬獣医治療市場：タイプ別市場シェア、2022年 ・医薬品、ワクチン、その他 世界の馬獣医治療市場：用途別、2018年-2023年、2024年-2029年 世界の馬獣医治療市場：用途別市場シェア、2022年 ・動物病院、動物病院、その他 世界の馬獣医治療市場：地域・国別、2018年-2023年、2024年-2029年 世界の馬獣医治療市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における馬獣医治療のグローバル売上、2018年-2023年 ・主要企業における馬獣医治療のグローバル売上シェア、2022年 ・主要企業における馬獣医治療のグローバル販売量、2018年-2023年 ・主要企業における馬獣医治療のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Boehringer Ingelheim、 Merck Animal Health、 Zoetis、 Elanco Animal Health、 Dechra Veterinary Products、 CEVA、 Virbac、 Norbrook Equine、 Kyoritsu Seiyaku、 Vetoquinol、 Protexin Healthcare、 Audevard ************************************************************* ・調査・分析レポートの概要 馬獣医治療市場の定義 市場セグメント 世界の馬獣医治療市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の馬獣医治療市場規模 世界の馬獣医治療市場規模：2022年 VS 2029年 世界の馬獣医治療市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの馬獣医治療の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の馬獣医治療製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：医薬品、ワクチン、その他 馬獣医治療のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：動物病院、動物病院、その他 馬獣医治療の用途別グローバル売上・予測 ・地域別市場分析 地域別馬獣医治療市場規模 2022年と2029年 地域別馬獣医治療売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Boehringer Ingelheim、 Merck Animal Health、 Zoetis、 Elanco Animal Health、 Dechra Veterinary Products、 CEVA、 Virbac、 Norbrook Equine、 Kyoritsu Seiyaku、 Vetoquinol、 Protexin Healthcare、 Audevard ... |
This research report provides a comprehensive analysis of the Equine Veterinary Therapeutics market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Equine Veterinary Therapeutics market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Equine Veterinary Therapeutics, challenges faced by the industry, and potential opportunities for market players.
The global Equine Veterinary Therapeutics market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Equine Veterinary Therapeutics market presents opportunities for various stakeholders, including Veterinary Hospital, Veterinary Clinics. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Equine Veterinary Therapeutics market. Additionally, the growing consumer demand present avenues for market expansion.
The global Equine Veterinary Therapeutics market was valued at US$ 1186.5 million in 2022 and is projected to reach US$ 1968 million by 2029, at a CAGR of 7.2% during the forecast period.
A significant driver in the Equine Veterinary Therapeutics market is the growing demand for high-quality healthcare and treatment options for horses. As the importance of equines in various sectors, including sports, agriculture, and leisure, continues to rise, there is an increased emphasis on maintaining their health and performance. This drives the demand for innovative veterinary therapeutics, such as advanced medications, surgical techniques, and rehabilitation methods, to address a wide range of equine health issues. One of the key challenges in this market is the cost associated with advanced equine veterinary care. High-end treatments, specialized surgeries, and cutting-edge therapies can be expensive, which may limit access for some horse owners or require substantial investments. Additionally, ensuring the safety and effectiveness of equine therapeutics can be challenging due to the size and unique physiology of horses, requiring specialized expertise and equipment. Regulatory compliance and ensuring the welfare of the animals also pose ongoing challenges in this industry.
Key Features:
The research report on the Equine Veterinary Therapeutics market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Equine Veterinary Therapeutics market.
Market Overview: The report provides a comprehensive overview of the Equine Veterinary Therapeutics market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Drugs, Vaccine), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Equine Veterinary Therapeutics market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Equine Veterinary Therapeutics market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Equine Veterinary Therapeutics market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Equine Veterinary Therapeutics market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Equine Veterinary Therapeutics market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Equine Veterinary Therapeutics market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Equine Veterinary Therapeutics, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Equine Veterinary Therapeutics market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Equine Veterinary Therapeutics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Drugs
Vaccine
Other
Market segment by Application
Veterinary Hospital
Veterinary Clinics
Other
Global Equine Veterinary Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Boehringer Ingelheim
Merck Animal Health
Zoetis
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Outline of Major Chapters:
Chapter 1: Introduces the definition of Equine Veterinary Therapeutics, market overview.
Chapter 2: Global Equine Veterinary Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Equine Veterinary Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Equine Veterinary Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Equine Veterinary Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Equine Veterinary Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Equine Veterinary Therapeutics Overall Market Size
2.1 Global Equine Veterinary Therapeutics Market Size: 2022 VS 2029
2.2 Global Equine Veterinary Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Equine Veterinary Therapeutics Players in Global Market
3.2 Top Global Equine Veterinary Therapeutics Companies Ranked by Revenue
3.3 Global Equine Veterinary Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Equine Veterinary Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Equine Veterinary Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Equine Veterinary Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Equine Veterinary Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Equine Veterinary Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Equine Veterinary Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Drugs
4.1.3 Vaccine
4.1.4 Other
4.2 By Type – Global Equine Veterinary Therapeutics Revenue & Forecasts
4.2.1 By Type – Global Equine Veterinary Therapeutics Revenue, 2018-2023
4.2.2 By Type – Global Equine Veterinary Therapeutics Revenue, 2024-2029
4.2.3 By Type – Global Equine Veterinary Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Equine Veterinary Therapeutics Market Size, 2022 & 2029
5.1.2 Veterinary Hospital
5.1.3 Veterinary Clinics
5.1.4 Other
5.2 By Application – Global Equine Veterinary Therapeutics Revenue & Forecasts
5.2.1 By Application – Global Equine Veterinary Therapeutics Revenue, 2018-2023
5.2.2 By Application – Global Equine Veterinary Therapeutics Revenue, 2024-2029
5.2.3 By Application – Global Equine Veterinary Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Equine Veterinary Therapeutics Market Size, 2022 & 2029
6.2 By Region – Global Equine Veterinary Therapeutics Revenue & Forecasts
6.2.1 By Region – Global Equine Veterinary Therapeutics Revenue, 2018-2023
6.2.2 By Region – Global Equine Veterinary Therapeutics Revenue, 2024-2029
6.2.3 By Region – Global Equine Veterinary Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Equine Veterinary Therapeutics Revenue, 2018-2029
6.3.2 US Equine Veterinary Therapeutics Market Size, 2018-2029
6.3.3 Canada Equine Veterinary Therapeutics Market Size, 2018-2029
6.3.4 Mexico Equine Veterinary Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Equine Veterinary Therapeutics Revenue, 2018-2029
6.4.2 Germany Equine Veterinary Therapeutics Market Size, 2018-2029
6.4.3 France Equine Veterinary Therapeutics Market Size, 2018-2029
6.4.4 U.K. Equine Veterinary Therapeutics Market Size, 2018-2029
6.4.5 Italy Equine Veterinary Therapeutics Market Size, 2018-2029
6.4.6 Russia Equine Veterinary Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries Equine Veterinary Therapeutics Market Size, 2018-2029
6.4.8 Benelux Equine Veterinary Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Equine Veterinary Therapeutics Revenue, 2018-2029
6.5.2 China Equine Veterinary Therapeutics Market Size, 2018-2029
6.5.3 Japan Equine Veterinary Therapeutics Market Size, 2018-2029
6.5.4 South Korea Equine Veterinary Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia Equine Veterinary Therapeutics Market Size, 2018-2029
6.5.6 India Equine Veterinary Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Equine Veterinary Therapeutics Revenue, 2018-2029
6.6.2 Brazil Equine Veterinary Therapeutics Market Size, 2018-2029
6.6.3 Argentina Equine Veterinary Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Equine Veterinary Therapeutics Revenue, 2018-2029
6.7.2 Turkey Equine Veterinary Therapeutics Market Size, 2018-2029
6.7.3 Israel Equine Veterinary Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia Equine Veterinary Therapeutics Market Size, 2018-2029
6.7.5 UAE Equine Veterinary Therapeutics Market Size, 2018-2029
7 Equine Veterinary Therapeutics Companies Profiles
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Company Summary
7.1.2 Boehringer Ingelheim Business Overview
7.1.3 Boehringer Ingelheim Equine Veterinary Therapeutics Major Product Offerings
7.1.4 Boehringer Ingelheim Equine Veterinary Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Boehringer Ingelheim Key News & Latest Developments
7.2 Merck Animal Health
7.2.1 Merck Animal Health Company Summary
7.2.2 Merck Animal Health Business Overview
7.2.3 Merck Animal Health Equine Veterinary Therapeutics Major Product Offerings
7.2.4 Merck Animal Health Equine Veterinary Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Merck Animal Health Key News & Latest Developments
7.3 Zoetis
7.3.1 Zoetis Company Summary
7.3.2 Zoetis Business Overview
7.3.3 Zoetis Equine Veterinary Therapeutics Major Product Offerings
7.3.4 Zoetis Equine Veterinary Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Zoetis Key News & Latest Developments
7.4 Elanco Animal Health
7.4.1 Elanco Animal Health Company Summary
7.4.2 Elanco Animal Health Business Overview
7.4.3 Elanco Animal Health Equine Veterinary Therapeutics Major Product Offerings
7.4.4 Elanco Animal Health Equine Veterinary Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Elanco Animal Health Key News & Latest Developments
7.5 Dechra Veterinary Products
7.5.1 Dechra Veterinary Products Company Summary
7.5.2 Dechra Veterinary Products Business Overview
7.5.3 Dechra Veterinary Products Equine Veterinary Therapeutics Major Product Offerings
7.5.4 Dechra Veterinary Products Equine Veterinary Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Dechra Veterinary Products Key News & Latest Developments
7.6 CEVA
7.6.1 CEVA Company Summary
7.6.2 CEVA Business Overview
7.6.3 CEVA Equine Veterinary Therapeutics Major Product Offerings
7.6.4 CEVA Equine Veterinary Therapeutics Revenue in Global Market (2018-2023)
7.6.5 CEVA Key News & Latest Developments
7.7 Virbac
7.7.1 Virbac Company Summary
7.7.2 Virbac Business Overview
7.7.3 Virbac Equine Veterinary Therapeutics Major Product Offerings
7.7.4 Virbac Equine Veterinary Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Virbac Key News & Latest Developments
7.8 Norbrook Equine
7.8.1 Norbrook Equine Company Summary
7.8.2 Norbrook Equine Business Overview
7.8.3 Norbrook Equine Equine Veterinary Therapeutics Major Product Offerings
7.8.4 Norbrook Equine Equine Veterinary Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Norbrook Equine Key News & Latest Developments
7.9 Kyoritsu Seiyaku
7.9.1 Kyoritsu Seiyaku Company Summary
7.9.2 Kyoritsu Seiyaku Business Overview
7.9.3 Kyoritsu Seiyaku Equine Veterinary Therapeutics Major Product Offerings
7.9.4 Kyoritsu Seiyaku Equine Veterinary Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Kyoritsu Seiyaku Key News & Latest Developments
7.10 Vetoquinol
7.10.1 Vetoquinol Company Summary
7.10.2 Vetoquinol Business Overview
7.10.3 Vetoquinol Equine Veterinary Therapeutics Major Product Offerings
7.10.4 Vetoquinol Equine Veterinary Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Vetoquinol Key News & Latest Developments
7.11 Protexin Healthcare
7.11.1 Protexin Healthcare Company Summary
7.11.2 Protexin Healthcare Business Overview
7.11.3 Protexin Healthcare Equine Veterinary Therapeutics Major Product Offerings
7.11.4 Protexin Healthcare Equine Veterinary Therapeutics Revenue in Global Market (2018-2023)
7.11.5 Protexin Healthcare Key News & Latest Developments
7.12 Audevard
7.12.1 Audevard Company Summary
7.12.2 Audevard Business Overview
7.12.3 Audevard Equine Veterinary Therapeutics Major Product Offerings
7.12.4 Audevard Equine Veterinary Therapeutics Revenue in Global Market (2018-2023)
7.12.5 Audevard Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
